Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2010

Open Access 01-12-2010 | Study protocol

Design of a randomized trial to evaluate the influence of mobile phone reminders on adherence to first line antiretroviral treatment in South India - the HIVIND study protocol

Authors: Ayesha De Costa, Anita Shet, Nagalingeswaran Kumarasamy, Per Ashorn, Bo Eriksson, Lennart Bogg, Vinod K Diwan, the HIVIND study team

Published in: BMC Medical Research Methodology | Issue 1/2010

Login to get access

Abstract

Background

Poor adherence to antiretroviral treatment has been a public health challenge associated with the treatment of HIV. Although different adherence-supporting interventions have been reported, their long term feasibility in low income settings remains uncertain. Thus, there is a need to explore sustainable contextual adherence aids in such settings, and to test these using rigorous scientific designs. The current ubiquity of mobile phones in many resource-constrained settings, make it a contextually appropriate and relatively low cost means of supporting adherence. In India, mobile phones have wide usage and acceptability and are potentially feasible tools for enhancing adherence to medications. This paper presents the study protocol for a trial, to evaluate the influence of mobile phone reminders on adherence to first-line antiretroviral treatment in South India.

Methods/Design

600 treatment naïve patients eligible for first-line treatment as per the national antiretroviral treatment guidelines will be recruited into the trial at two clinics in South India. Patients will be randomized into control and intervention arms. The control arm will receive the standard of care; the intervention arm will receive the standard of care plus mobile phone reminders. Each reminder will take the form of an automated call and a picture message. Reminders will be delivered once a week, at a time chosen by the patient. Patients will be followed up for 24 months or till the primary outcome i.e. virological failure, is reached, whichever is earlier. Self-reported adherence is a secondary outcome. Analysis is by intention-to-treat. A cost-effectiveness study of the intervention will also be carried out.

Discussion

Stepping up telecommunications technology in resource-limited healthcare settings is a priority of the World Health Organization. The trial will evaluate if the use of mobile phone reminders can influence adherence to first-line antiretrovirals in an Indian context.

Trial Registration

Trial registration: ISRCTN79261738.
Appendix
Available only for authorised users
Literature
2.
go back to reference Chesney MA, Morin M, Sherr L: Adherence to HIV combination therapy. Soc Sci Med. 2000, 50 (11): 1599-1605. 10.1016/S0277-9536(99)00468-2.CrossRefPubMed Chesney MA, Morin M, Sherr L: Adherence to HIV combination therapy. Soc Sci Med. 2000, 50 (11): 1599-1605. 10.1016/S0277-9536(99)00468-2.CrossRefPubMed
3.
go back to reference Boden D, Hurley A, Zhang L, Cao Y, Guo Y, Jones E, Tsay J, Ip J, Farthing C, Limoli K, et al: HIV-1 drug resistance in newly infected individuals. JAMA. 1999, 282 (12): 1135-1141. 10.1001/jama.282.12.1135.CrossRefPubMed Boden D, Hurley A, Zhang L, Cao Y, Guo Y, Jones E, Tsay J, Ip J, Farthing C, Limoli K, et al: HIV-1 drug resistance in newly infected individuals. JAMA. 1999, 282 (12): 1135-1141. 10.1001/jama.282.12.1135.CrossRefPubMed
4.
go back to reference Friedland GH, Williams A: Attaining higher goals in HIV treatment: the central importance of adherence. AIDS. 1999, 13 (Suppl 1): S61-72.PubMed Friedland GH, Williams A: Attaining higher goals in HIV treatment: the central importance of adherence. AIDS. 1999, 13 (Suppl 1): S61-72.PubMed
5.
go back to reference Chesney M: Adherence to HAART regimens. AIDS Patient Care STDS. 2003, 17 (4): 169-177. 10.1089/108729103321619773.CrossRefPubMed Chesney M: Adherence to HAART regimens. AIDS Patient Care STDS. 2003, 17 (4): 169-177. 10.1089/108729103321619773.CrossRefPubMed
6.
go back to reference Conway B: The role of adherence to antiretroviral therapy in the management of HIV infection. J Acquir Immune Defic Syndr. 2007, 45 (Suppl 1): S14-18.CrossRefPubMed Conway B: The role of adherence to antiretroviral therapy in the management of HIV infection. J Acquir Immune Defic Syndr. 2007, 45 (Suppl 1): S14-18.CrossRefPubMed
7.
go back to reference Bangsberg DR: Modified directly observed therapy to improve HIV treatment outcomes: little impact with potent, once-daily therapy in unselected antiretroviral-naive patients. Curr HIV/AIDS Rep. 2009, 6 (4): 173-174. 10.1007/s11904-009-0031-y.CrossRefPubMed Bangsberg DR: Modified directly observed therapy to improve HIV treatment outcomes: little impact with potent, once-daily therapy in unselected antiretroviral-naive patients. Curr HIV/AIDS Rep. 2009, 6 (4): 173-174. 10.1007/s11904-009-0031-y.CrossRefPubMed
8.
go back to reference Gross R, Tierney C, Andrade A, Lalama C, Rosenkranz S, Eshleman SH, Flanigan T, Santana J, Salomon N, Reisler R, et al: Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial. Arch Intern Med. 2009, 169 (13): 1224-1232. 10.1001/archinternmed.2009.172.CrossRefPubMedPubMedCentral Gross R, Tierney C, Andrade A, Lalama C, Rosenkranz S, Eshleman SH, Flanigan T, Santana J, Salomon N, Reisler R, et al: Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial. Arch Intern Med. 2009, 169 (13): 1224-1232. 10.1001/archinternmed.2009.172.CrossRefPubMedPubMedCentral
9.
go back to reference Rueda S, Park-Wyllie LY, Bayoumi AM, Tynan AM, Antoniou TA, Rourke SB, Glazier RH: Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Syst Rev. 2006, 3: CD001442-PubMed Rueda S, Park-Wyllie LY, Bayoumi AM, Tynan AM, Antoniou TA, Rourke SB, Glazier RH: Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Syst Rev. 2006, 3: CD001442-PubMed
10.
go back to reference Curioso WH, Kurth AE: Access, use and perceptions regarding Internet, cell phones and PDAs as a means for health promotion for people living with HIV in Peru. BMC Med Inform Decis Mak. 2007, 7: 24-10.1186/1472-6947-7-24.CrossRefPubMedPubMedCentral Curioso WH, Kurth AE: Access, use and perceptions regarding Internet, cell phones and PDAs as a means for health promotion for people living with HIV in Peru. BMC Med Inform Decis Mak. 2007, 7: 24-10.1186/1472-6947-7-24.CrossRefPubMedPubMedCentral
11.
go back to reference Morris K: Mobile phones connecting efforts to tackle infectious disease. Lancet Infect Dis. 2009, 9 (5): 274-10.1016/S1473-3099(09)70118-5.CrossRefPubMed Morris K: Mobile phones connecting efforts to tackle infectious disease. Lancet Infect Dis. 2009, 9 (5): 274-10.1016/S1473-3099(09)70118-5.CrossRefPubMed
12.
go back to reference Lester R, Karanja S: Mobile phones: exceptional tools for HIV/AIDS, health, and crisis management. Lancet Infect Dis. 2008, 8 (12): 738-739. 10.1016/S1473-3099(08)70265-2.CrossRefPubMed Lester R, Karanja S: Mobile phones: exceptional tools for HIV/AIDS, health, and crisis management. Lancet Infect Dis. 2008, 8 (12): 738-739. 10.1016/S1473-3099(08)70265-2.CrossRefPubMed
14.
go back to reference Kaplan WA: Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries?. Global Health. 2006, 2: 9-10.1186/1744-8603-2-9.CrossRefPubMedPubMedCentral Kaplan WA: Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries?. Global Health. 2006, 2: 9-10.1186/1744-8603-2-9.CrossRefPubMedPubMedCentral
15.
go back to reference Ybarra ML, Bull SS: Current trends in Internet- and cell phone-based HIV prevention and intervention programs. Curr HIV/AIDS Rep. 2007, 4 (4): 201-207. 10.1007/s11904-007-0029-2.CrossRefPubMed Ybarra ML, Bull SS: Current trends in Internet- and cell phone-based HIV prevention and intervention programs. Curr HIV/AIDS Rep. 2007, 4 (4): 201-207. 10.1007/s11904-007-0029-2.CrossRefPubMed
16.
go back to reference Chang LW, Kagaayi J, Nakigozi G, Packer AH, Serwadda D, Quinn TC, Gray RH, Bollinger RC, Reynolds SJ: Responding to the human resource crisis: peer health workers, mobile phones, and HIV care in Rakai, Uganda. AIDS Patient Care STDS. 2008, 22 (3): 173-174. 10.1089/apc.2007.0234.CrossRefPubMedPubMedCentral Chang LW, Kagaayi J, Nakigozi G, Packer AH, Serwadda D, Quinn TC, Gray RH, Bollinger RC, Reynolds SJ: Responding to the human resource crisis: peer health workers, mobile phones, and HIV care in Rakai, Uganda. AIDS Patient Care STDS. 2008, 22 (3): 173-174. 10.1089/apc.2007.0234.CrossRefPubMedPubMedCentral
17.
go back to reference Lester RT, Mills EJ, Kariri A, Ritvo P, Chung M, Jack W, Habyarimana J, Karanja S, Barasa S, Nguti R, et al: The HAART cell phone adherence trial (WelTel Kenya1): a randomized controlled trial protocol. Trials. 2009, 10: 87-10.1186/1745-6215-10-87.CrossRefPubMedPubMedCentral Lester RT, Mills EJ, Kariri A, Ritvo P, Chung M, Jack W, Habyarimana J, Karanja S, Barasa S, Nguti R, et al: The HAART cell phone adherence trial (WelTel Kenya1): a randomized controlled trial protocol. Trials. 2009, 10: 87-10.1186/1745-6215-10-87.CrossRefPubMedPubMedCentral
21.
go back to reference Friendlander AH, Ettinger RL: Karnofsky performance status scale. Spec Care Dentist. 2009, 29 (4): 147-148. 10.1111/j.1754-4505.2009.00088.x.CrossRefPubMed Friendlander AH, Ettinger RL: Karnofsky performance status scale. Spec Care Dentist. 2009, 29 (4): 147-148. 10.1111/j.1754-4505.2009.00088.x.CrossRefPubMed
22.
go back to reference Doig GS, Simpson F: Randomization and allocation concealment: a practical guide for researchers. J Crit Care. 2005, 20 (2): 187-191. 10.1016/j.jcrc.2005.04.005. discussion 191-183CrossRefPubMed Doig GS, Simpson F: Randomization and allocation concealment: a practical guide for researchers. J Crit Care. 2005, 20 (2): 187-191. 10.1016/j.jcrc.2005.04.005. discussion 191-183CrossRefPubMed
23.
go back to reference Shet A, Kumar K, Rodrigues R, Rajagopalan N, D'Souza G, De Costa A: Designing a Mobile Phone-Based Intervention to Promote Adherence to Antiretroviral Therapy in South India. Aids Behav. 2010, Shet A, Kumar K, Rodrigues R, Rajagopalan N, D'Souza G, De Costa A: Designing a Mobile Phone-Based Intervention to Promote Adherence to Antiretroviral Therapy in South India. Aids Behav. 2010,
24.
go back to reference Chesney MA, Ickovics JR, Chambers DB: Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care. 2000, 12: 255-266. 10.1080/09540120050042891.CrossRefPubMed Chesney MA, Ickovics JR, Chambers DB: Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care. 2000, 12: 255-266. 10.1080/09540120050042891.CrossRefPubMed
25.
go back to reference Rivet Amico KR, Fisher WA, Cornman DH, et al: Visual Analog Scale of ART Adherence: Association With 3-Day Self-Report and Adherence Barriers. J Acquir Immune Defic Syndr. 2006, 42: 455-459. 10.1097/01.qai.0000225020.73760.c2.CrossRefPubMed Rivet Amico KR, Fisher WA, Cornman DH, et al: Visual Analog Scale of ART Adherence: Association With 3-Day Self-Report and Adherence Barriers. J Acquir Immune Defic Syndr. 2006, 42: 455-459. 10.1097/01.qai.0000225020.73760.c2.CrossRefPubMed
26.
go back to reference Gu M, Lai TL: Determination of power and sample size in the design of clinical trials with failure-time endpoints and interim analyses. Control Clin Trials. 1999, 20 (5): 423-438. 10.1016/S0197-2456(99)00021-5.CrossRefPubMed Gu M, Lai TL: Determination of power and sample size in the design of clinical trials with failure-time endpoints and interim analyses. Control Clin Trials. 1999, 20 (5): 423-438. 10.1016/S0197-2456(99)00021-5.CrossRefPubMed
27.
go back to reference Lampe FC, Gatell JM, Staszewski S, Johnson MA, Pradier C, Gill MJ, de Lazzari E, Dauer B, Youle M, Fontas E, et al: Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002. Arch Intern Med. 2006, 166 (5): 521-528. 10.1001/archinte.166.5.521.CrossRefPubMed Lampe FC, Gatell JM, Staszewski S, Johnson MA, Pradier C, Gill MJ, de Lazzari E, Dauer B, Youle M, Fontas E, et al: Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002. Arch Intern Med. 2006, 166 (5): 521-528. 10.1001/archinte.166.5.521.CrossRefPubMed
28.
go back to reference Reynolds NR, Testa MA, Su M, Chesney MA, Neidig JL, Frank I, Smith S, Ickovics J, Robbins GK: Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. J Acquir Immune Defic Syndr. 2008, 47 (1): 62-68. 10.1097/QAI.0b013e3181582d54.CrossRefPubMed Reynolds NR, Testa MA, Su M, Chesney MA, Neidig JL, Frank I, Smith S, Ickovics J, Robbins GK: Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. J Acquir Immune Defic Syndr. 2008, 47 (1): 62-68. 10.1097/QAI.0b013e3181582d54.CrossRefPubMed
29.
go back to reference Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N: Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006, 43 (Suppl 1): S23-35.CrossRefPubMedPubMedCentral Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N: Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006, 43 (Suppl 1): S23-35.CrossRefPubMedPubMedCentral
30.
go back to reference World Health Organization: UNAIDS: Resource needs for an expanded response to AIDS in low- and middle-income countries. 2006, Geneva, WHO World Health Organization: UNAIDS: Resource needs for an expanded response to AIDS in low- and middle-income countries. 2006, Geneva, WHO
32.
go back to reference Collier AC, Ribaudo H, Mukherjee AL, Feinberg J, Fischl MA, Chesney M: A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy. J Infect Dis. 2005, 192 (8): 1398-1406. 10.1086/466526.CrossRefPubMed Collier AC, Ribaudo H, Mukherjee AL, Feinberg J, Fischl MA, Chesney M: A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy. J Infect Dis. 2005, 192 (8): 1398-1406. 10.1086/466526.CrossRefPubMed
Metadata
Title
Design of a randomized trial to evaluate the influence of mobile phone reminders on adherence to first line antiretroviral treatment in South India - the HIVIND study protocol
Authors
Ayesha De Costa
Anita Shet
Nagalingeswaran Kumarasamy
Per Ashorn
Bo Eriksson
Lennart Bogg
Vinod K Diwan
the HIVIND study team
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2010
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/1471-2288-10-25

Other articles of this Issue 1/2010

BMC Medical Research Methodology 1/2010 Go to the issue